Ex vivo expanded hematopoietic progenitor cells improve cardiac function after myocardial infarction: Role of β-catenin transduction and cell dose

Journal of Molecular and Cellular Cardiology

Volumn 45, Issue 3, 2008, Pages 394-403

  Templin, Christian ^a,b   Kotlarz, Daniel ^a   Faulhaber, Jörg ^c   Schnabel, Sabine ^a,e   Grote, Karsten ^a   Salguero, Gustavo ^a   Luchtefeld, Maren ^a   Hiller, Karl Heinz ^d   Jakob, Peter ^d   Naim, Hassan Y ^e   Schieffer, Bernhard ^a   Hilfiker Kleiner, Denise ^a   Landmesser, Ulf ^b   Limbourg, Florian P ^a   Drexler, Helmut ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

catenin; Cell transplantation; Gene transfer; Hematopoietic stem cells; Myocardial regeneration

Indexed keywords

BETA CATENIN; GREEN FLUORESCENT PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL LABELING; CELL RENEWAL; CELL THERAPY; CONTROLLED STUDY; EX VIVO STUDY; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPERFUSION INJURY; TREATMENT INDICATION; TREATMENT OUTCOME;

ANIMALS; BETA CATENIN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HEART; HEART FUNCTION TESTS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; LEUKOCYTE COUNT; MICE; MYOCARDIAL INFARCTION; MYOCARDIUM; TRANSDUCTION, GENETIC; VENTRICULAR REMODELING;

EID: 50849091926     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.06.010     Document Type: Article

References (38)

1. Braunwald E., and Bristow M.R. Congestive heart failure: fifty years of progress. Circulation 102 (2000) IV14-IV23
2. Colucci W.S. Molecular and cellular mechanisms of myocardial failure. Am. J. Cardiol. 80 (1997) 15L-25L
3. Pfeffer J.M., Pfeffer M.A., Fletcher P.J., and Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am. J. Physiol. 260 (1991) H1406-H1414
4. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
5. Wollert K.C., and Drexler H. Clinical applications of stem cells for the heart. Circ Res. 96 (2005) 151-163
6. Kamihata H., Matsubara H., Nishiue T., Fujiyama S., Tsutsumi Y., Ozono R., et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104 (2001) 1046-1052
7. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
8. Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355 (2006) 1210-1221
9. Misao Y., Takemura G., Arai M., Sato S., Suzuki K., Miyata S., et al. Bone marrow-derived myocyte-like cells and regulation of repair-related cytokines after bone marrow cell transplantation. Cardiovasc. Res. 69 (2006) 476-490
10. Stamm C., Westphal B., Kleine H.D., Petzsch M., Kittner C., Klinge H., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361 (2003) 45-46
11. Bartunek J., Vanderheyden M., Vandekerckhove B., Mansour S., De Bruyne B., De Bondt P., et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 112 (2005) I178-I183
12. Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 355 (2006) 1199-1209
13. Willert K., Brown J.D., Danenberg E., Duncan A.W., Weissman I.L., Reya T., et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423 (2003) 448-452
14. Sato N., Meijer L., Skaltsounis L., Greengard P., and Brivanlou A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10 (2004) 55-63
15. Chenn A., and Walsh C.A. Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 297 (2002) 365-369
16. Templin C., Kotlarz D., Rathinam C., Rudolph C., Schatzlein S., Ramireddy K., et al. Establishment of immortalized multipotent hematopoietic progenitor cell lines by retroviral-mediated gene transfer of beta-catenin. Exp. Hematol. 36 (2008) 204-215
17. Taylor D.A., Atkins B.Z., Hungspreugs P., Jones T.R., Reedy M.C., Hutcheson K.A., et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med. 4 (1998) 929-933
18. Li R.K., Jia Z.Q., Weisel R.D., Merante F., and Mickle D.A. Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J. Mol. Cell Cardiol. 31 (1999) 513-522
19. Templin C., Kotlarz D., Marquart F., Faulhaber J., Brendecke V., Schaefer A., et al. Transcoronary delivery of bone marrow cells to the infarcted murine myocardium: feasibility, cellular kinetics, and improvement in cardiac function. Basic Res. Cardiol. 101 (2006) 301-310
20. Fuchs M., Hilfiker A., Kaminski K., Hilfiker-Kleiner D., Guener Z., Klein G., et al. Role of interleukin-6 for LV remodeling and survival after experimental myocardial infarction. Faseb. J. 17 (2003) 2118-2120
21. Hilfiker-Kleiner D., Hilfiker A., Fuchs M., Kaminski K., Schaefer A., Schieffer B., et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ. Res. 95 (2004) 187-195
22. Schaefer A., Klein G., Brand B., Lippolt P., Drexler H., and Meyer G.P. Evaluation of left ventricular diastolic function by pulsed Doppler tissue imaging in mice. J. Am. Soc. Echocardiogr. 16 (2003) 1144-1149
23. Korte T., Fuchs M., Guener Z., v Bonin J., de Sousa M., Niehaus M., et al. In-vivo electrophysiological study in mice with chronic anterior myocardial infarction. J. Interv. Card Electrophysiol. 6 (2002) 121-132
24. Ruff J., Wiesmann F., Hiller K.H., Voll S., von Kienlin M., Bauer W.R., et al. Magnetic resonance microimaging for noninvasive quantification of myocardial function and mass in the mouse. Magn. Reson. Med. 40 (1998) 43-48
25. Nahrendorf M., Wiesmann F., Hiller K.H., Han H., Hu K., Waller C., et al. In vivo assessment of cardiac remodeling after myocardial infarction in rats by cine-magnetic resonance imaging. J. Cardiovasc. Magn. Reson. 2 (2000) 171-180
26. Grote K., Salguero G., Ballmaier M., Dangers M., Drexler H., and Schieffer B. The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells: potential role in angiogenesis and endothelial regeneration. Blood 110 (2007) 877-885
27. Assmus B., Schachinger V., Teupe C., Britten M., Lehmann R., Dobert N., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017
28. Giles R.H., van Es J.H., and Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653 (2003) 1-24
29. Hofmann M., Wollert K.C., Meyer G.P., Menke A., Arseniev L., Hertenstein B., et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111 (2005) 2198-2202
30. Xu M., Uemura R., Dai Y., Wang Y., Pasha Z., and Ashraf M. In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J. Mol. Cell Cardiol. 42 (2007) 441-448
31. Montessuit C., Palma T., Viglino C., Pellieux C., and Lerch R. Effects of insulin-like growth factor-I on the maturation of metabolism in neonatal rat cardiomyocytes. Pflugers Arch. 452 (2006) 380-386
32. Kinugawa S., Tsutsui H., Ide T., Nakamura R., Arimura K., Egashira K., et al. Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes. Cardiovasc. Res. 43 (1999) 157-164
33. Padua R.R., Merle P.L., Doble B.W., Yu C.H., Zahradka P., Pierce G.N., et al. FGF-2-induced negative inotropism and cardioprotection are inhibited by chelerythrine: involvement of sarcolemmal calcium-independent protein kinase C. J. Mol. Cell Cardiol. 30 (1998) 2695-2709
34. Ishibashi Y., Urabe Y., Tsutsui H., Kinugawa S., Sugimachi M., Takahashi M., et al. Negative inotropic effect of basic fibroblast growth factor on adult rat cardiac myocyte. Circulation 96 (1997) 2501-2504
35. Bick R.J., Liao J.P., King T.W., LeMaistre A., McMillin J.B., and Buja L.M. Temporal effects of cytokines on neonatal cardiac myocyte Ca2+ transients and adenylate cyclase activity. Am. J. Physiol. 272 (1997) H1937-1944
36. Gulick T., Chung M.K., Pieper S.J., Lange L.G., and Schreiner G.F. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 6753-6757
37. Lindsey M.L., Mann D.L., Entman M.L., and Spinale F.G. Extracellular matrix remodeling following myocardial injury. Ann. Med. 35 (2003) 316-326
38. Hahn J.Y., Cho H.J., Bae J.W., Yuk H.S., Kim K.I., Park K.W., et al. Beta-catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts. J. Biol. Chem. 281 (2006) 30979-30989